Joseph Leach

Dr. Leach brings over 20 years of experience as a clinician, researcher and health care leader to his role. He will lead the expansion of Prime's specialty management capabilities and help shape the company's total drug management strategy.

Dr. Leach will partner with Blue Plan medical directors and pharmacy leaders to drive adoption of specialty and total drug management solutions. Dr. Leach brings deep experience as a medical oncologist and researcher to help the company's clients and members navigate an era when million-dollar curative therapies – many in the oncology space – are coming to market.

He has held numerous leadership roles including medical director of Virginia Piper Cancer Institute in Minneapolis, past president of the Minnesota Society of Clinical Oncology and principal investigator for the Metro-Minnesota Community Oncology Research Consortium.

Dr. Leach has also held national leadership positions in research including committee chair for the Eastern Cooperative Oncology Group (ECOG), which was one of the first publicly funded cooperative groups to perform multi-center clinical trials for cancer research. He was appointed to the NCI Thoracic Malignancy Steering Committee, an organization that directs the national research priorities and approves clinical trial concepts for lung cancer research.

Dr. Leach holds a Bachelor of Arts degree in biology from St. Olaf College in Northfield, Minn. and earned a Doctor of Medicine degree from the University of Minnesota in Minneapolis. He completed training in internal medicine and medical oncology at the University of Oklahoma in Oklahoma City and is a board-certified medical oncologist.